Home › Essential Thrombocythemia › Maryland › Baltimore
Essential Thrombocythemia clinical trials in Baltimore, MD
5 studies for Essential Thrombocythemia are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- John Hopkins Hospital, Baltimore
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Johns Hopkins Medicine-the Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US18, Baltimore
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Johns Hopkins University, Baltimore
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Johns Hopkins Hospital, Baltimore
Essential Thrombocythemia trials in other cities
- New York City, NY8 studies
- Durham, NC7 studies
- Nashville, TN5 studies
- Salt Lake City, UT5 studies
- Boston, MA5 studies
- Mountain View, CA4 studies
- Irvine, CA4 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- Houston, TX4 studies
- St. Louis, MO4 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Prostate Cancer45 studies
- Breast Cancer44 studies
- Lung Cancer41 studies
- Cancer (all types)36 studies
- Colorectal Cancer30 studies
- Pancreatic Cancer30 studies
- Metastatic Cancer26 studies
- Obesity24 studies
- Bladder Cancer24 studies
- Ovarian Cancer23 studies
- Heart Failure23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.